Results 171 to 180 of about 42,053 (270)

Kidney Effectiveness and Safety of Adding Spironolactone in Patients With Type 2 Diabetes Receiving Renin–Angiotensin System Inhibitors Therapy

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT We evaluated the renal outcomes and safety of spironolactone added to renin–angiotensin system inhibitors (RASis) among patients with type 2 diabetes (T2D), given its uncertain role alongside RASis, the cornerstone of T2D with renal disease management.
Wei‐Ren Lin, Tzu‐Shan Huang, Ho‐Hsiang Chang, Jo‐Yen Chao, Yi‐Hsin Chang, Chen‐Yi Yang, Huang‐Tz Ou, Wei‐Hung Lin   +7 more
wiley   +1 more source

Addressing SARS-CoV-2 viroporins with antiarrhythmic drugs. [PDF]

Europace
Bloothooft M, Voigt N, de Boer TP.
europepmc   +1 more source

Catheter Ablation vs. Antiarrhythmic Drugs as Therapy for Paroxysmal Atrial Fibrillation. [PDF]

J Gen Intern Med, 2022
Carter J, Sato T, Burke H.
europepmc   +1 more source

QT Myopia and Cardiac Safety: Expanding the Aperture of Arrhythmia Assessment in Early Phase Drug Development

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Regulatory agencies such as the Food and Drug Administration (FDA), European Medicines Agency (EMA), Health Canada, and the Japanese Pharmaceutical and Medical Device Agency (PMDA) provide scientific and public health guidance with cardiac safety being paramount in drug development of new investigational products (IP).
Robert M. Lester, Katherine Clark, Sabina Paglialunga   +2 more
wiley   +1 more source

Bachmann's Bundle‐Related Atrial Tachycardias Following Catheter Ablation of Persistent Atrial Fibrillation

Journal of Cardiovascular Electrophysiology, Volume 37, Issue 3, Page 561-571, March 2026.
ABSTRACT Background Atrial tachycardias (AT) after radiofrequency ablation (RFA) of atrial fibrillation (AF) may utilize Bachmann's bundle (BB). Due to their epicardial location, these ATs remain poorly understood. Objective To describe the electrophysiologic and anatomic basis of BB‐related ATs.
Nate Christian‐Miller, Mohammed Al‐Sadawi, Muazzum Shah, Kelly Arps, Amrish Deshmukh, Jackson J. Liang, Krit Jongnarangsin, Fred Morady, Hakan Oral, Aman Chugh, Michael Ghannam   +10 more
wiley   +1 more source

Antiarrhythmic Drugs

, 2013
SM Raju, AK Kapoor
  +7 more sources

Automaticity of the Pulmonary Vein Myocardium and the Effect of Class I Antiarrhythmic Drugs. [PDF]

Int J Mol Sci
Namekata I, Seki M, Saito T, Odaka R, Hamaguchi S, Tanaka H.   +5 more
europepmc   +1 more source

The Effectiveness of Catheter Ablation in the Management of Ventricular Tachycardia in Comparison With Antiarrhythmic Drugs in Patients With Structural Heart Disease: A Meta-Analysis. [PDF]

Cureus, 2023
Karedath J, Valle Villatoro AL, Faisal S, Kathuria Anand I, Anirudh Chunchu V, Umer M, Ala S, Amin A.   +7 more
europepmc   +1 more source

Very High‐Power Short‐Duration Ablation for Premature Ventricular Complexes From Sites With Suboptimal Catheter Stability

Journal of Cardiovascular Electrophysiology, Volume 37, Issue 3, Page 652-654, March 2026.
ABSTRACT Introduction While very high‐power short‐duration (vHPSD) ablation has been shown to be safe and effective for ablation of atrial fibrillation, the utility of vHPSD ablation for targeting premature ventricular complexes (PVCs) remains unclear.
Heather Wheat, Kelly Arps, Amrish Deshmukh, Michael Ghannam, Frank Bogun, Jackson J. Liang   +5 more
wiley   +1 more source

Evaluating In-Hospital Arrhythmias in Critically Ill Acute Kidney Injury Patients: Predictive Models, Mortality Risks, and the Efficacy of Antiarrhythmic Drugs. [PDF]

J Clin Med
Xie W, Franz H, Yakulov TA.
europepmc   +1 more source